Christine Hemmings

Christine Hemmings is a Clinical Associate Professor at the UWA Medical School, University of Western Australia, and serves as Lead GI Pathologist at Capital Pathology since 2024. Her academic career spans multiple decades with significant contributions to pathology and cancer research, including 50 documented research outputs and an h-index of 12.

Her educational background includes:

• Bachelor of Human Biology, University of Auckland (1987-1989)
• MBChB in Medicine (1990-1992)
• PhD in Medicine focusing on pathologic assessment of rectal carcinoma (2009-2017)
• Postgraduate Diploma in Bioethics and Law, University of Otago (2022-2023)

Dr. Hemmings' research primarily focuses on gastrointestinal oncology and cancer diagnostics, with expertise in tumor regression, chemoradiotherapy response, and molecular characterization of colorectal cancers. Her fingerprint analysis shows strong engagement in Malignant Neoplasm research (100%), Pathology (77%), Cell Density (75%), and SOX2-related studies (67%). She has made substantial contributions to developing standardized reporting protocols through the International Collaboration on Cancer Reporting (ICCR).

Her recent publications demonstrate a clear trend toward establishing standardized diagnostic frameworks for various cancers, including gastrointestinal stromal tumors, soft-tissue sarcomas, and neuroendocrine neoplasms. Her 2025 research on post-colonoscopy colorectal cancer examines patient outcomes and molecular characteristics, bridging clinical practice with research to improve diagnostic accuracy and patient care.

Her notable recognition includes:

• RCPA Meritorious Service Award (2018)

Dr. Hemmings has maintained a long-standing commitment to the pathology community as a Member of the editorial board for Pathology journal since 2009 and as Associate Editor since 2021. Her recent work addressing gender inequity in pathology demonstrates her broader engagement with professional development issues in medicine.

Her international collaborations through the ICCR reflect her commitment to advancing pathology practice globally, aiming to improve consistency and quality in cancer diagnosis worldwide through standardized reporting protocols.